For centuries, chamomile has served as a traditional remedy for restlessness, digestive discomfort, and chronic inflammatory conditions. Lately, scientific inquiry has intensified into its possible cancer-fighting properties. Controlled lab experiments have demonstrated that specific bioactive compounds in chamomile—particularly the compounds apigenin and luteolin—may slow the multiplication of cancer cells in cell cultures. These flavonoids appear to disrupt critical cellular mechanisms that enable cancer cells to spread rapidly. For https://asresalamat.ir/7-properties-of-chamomile-tea-what-is-chamomile-tea-good-for/ (linked webpage) example suggests that apigenin can trigger apoptosis—programmed cell death—in tumor cells while leaving intact healthy cells. The documented outcomes have been recorded in tissue samples of cancers of the breast, prostate, skin, and GI tract. However, these findings stem from non-human systems and cannot be assumed to the same outcomes in human patients. Clinical trials involving chamomile extracts in individuals undergoing cancer therapy remain insufficiently extensive. Although drinking chamomile tea or chamomile supplements is generally regarded as safe for healthy adults, they must not be seen as standard cancer therapies. Investigations are ongoing to explore whether chamomile compounds could enhance established cancer protocols or reduce treatment-related side effects such as inflammation and oxidative stress. Higher-quality prospective randomized trials are urgently needed to determine whether chamomile can contribute meaningfully in lowering tumor incidence or cancer treatment. For now, chamomile remains a compelling candidate for further investigation—but not a validated remedy.